138 related articles for article (PubMed ID: 555037)
1. [Treatment of benign breast pathology with bromocriptine].
Tolino A; Cardone A; Mastrantonio P; Chiacchio G
Riv Ital Ginecol; 1977; 58(5):371-8. PubMed ID: 555037
[No Abstract] [Full Text] [Related]
2. Benign breast disease.
Mauvais-Jarvis P; Kuttenn F
Curr Ther Endocrinol Metab; 1994; 5():364-70. PubMed ID: 7704754
[No Abstract] [Full Text] [Related]
3. [Bromocriptine in fibro-cystic mastopathy].
Marzetti L; Framarino ML; Dei Malatesta ML; Aragona C; De Angelis R
Riv Ital Ginecol; 1980; 59(4-5):357-64. PubMed ID: 7313397
[No Abstract] [Full Text] [Related]
4. [Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline].
Mussa A; Sandrucci S; Dogliotti L
Minerva Med; 1979 Nov; 70(51):3493-8. PubMed ID: 522987
[TBL] [Abstract][Full Text] [Related]
5. Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154).
Santoro C; Cappa M; Moretti C; Fabbri A; La Vecchia V; Romano Marcellino L; Fraioli F
Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):479-81. PubMed ID: 6815107
[TBL] [Abstract][Full Text] [Related]
6. Short-term tamoxifen treatment in benign breast diseases.
Cupceancu B
Endocrinologie; 1985; 23(3):169-77. PubMed ID: 4048817
[TBL] [Abstract][Full Text] [Related]
7. [Mastodynia and fibrocystic disease of the breast. Perspectives and methods of medical treatment].
van Bogaert LJ
J Gynecol Obstet Biol Reprod (Paris); 1986; 15(6):805-11. PubMed ID: 3794218
[TBL] [Abstract][Full Text] [Related]
8. Treatment of benign breast disease with bromocriptine.
Mussa A; Dogliotti L
J Endocrinol Invest; 1979; 2(1):87-91. PubMed ID: 489922
[TBL] [Abstract][Full Text] [Related]
9. Mastalgia.
Preece PE
Practitioner; 1982 Aug; 226(1370):1373-82. PubMed ID: 7134151
[No Abstract] [Full Text] [Related]
10. Bromocriptine treatment of cyclical mastalgia/fibrocystic breast disease: update on the European trial.
Dogliotti L; Mansel RE
Br J Clin Pract Suppl; 1989 Nov; 68():26-32; discussion 49-53. PubMed ID: 2488563
[No Abstract] [Full Text] [Related]
11. Histologic changes in fibrocystic breast disease before and after treatment with bromocriptine.
Murta EF; de Freitas MM; Velludo MA
Rev Paul Med; 1992; 110(6):251-6. PubMed ID: 1341021
[TBL] [Abstract][Full Text] [Related]
12. [Use of infecundin in dyshormonal hyperplasia of the breast associated with ovarian dysfunction].
Mezinova NN
Sov Med; 1975 Jun; (6):85-90. PubMed ID: 1162479
[No Abstract] [Full Text] [Related]
13. [Treatment of fibrocystic mastopathy with bromocriptine].
López Rosales C; Castellanos Rodríguez J; García Carmona MR
Ginecol Obstet Mex; 1985 Aug; 53():233-6. PubMed ID: 3908225
[No Abstract] [Full Text] [Related]
14. Tamoxifen responders selection by computerized contact thermography in benign breast disease.
Cupceancu B; Mogoş I; Cotruţă C
Endocrinologie; 1986; 24(2):115-22. PubMed ID: 3738400
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment of mastopathy.
Márton Z; Gáti I; Doszpod J; Preisz J; Kecskés L
Acta Chir Acad Sci Hung; 1969; 10(1):93-103. PubMed ID: 4240634
[No Abstract] [Full Text] [Related]
16. Combined tamoxifen-lynestrenol treatment in benign breast disease.
Cupceancu B
Endocrinologie; 1985; 23(4):265-72. PubMed ID: 4089504
[TBL] [Abstract][Full Text] [Related]
17. [Clinical experience with Furazabol in mammary tumors, with special emphasis on mastopathy].
Watanuki S; Ito K; Nishikawa Y; Ajisaka H
Geka Chiryo; 1969 Apr; 20(4):470-4. PubMed ID: 5819735
[No Abstract] [Full Text] [Related]
18. Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-Br-alpha-ergocryptine (CB-154).
Martin-Comin J; Pujol-Amat P; Cararach V; Davi E; Robyn C
Obstet Gynecol; 1976 Dec; 48(6):703-6. PubMed ID: 1036613
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of cystic dysplasia of the breast by the trephine-sclerosing method].
Sanchakova AV; Dymarskiĭ LIu
Sov Med; 1975 Aug; (8):111-5. PubMed ID: 1233738
[No Abstract] [Full Text] [Related]
20. Evaluating benign breast disease.
Ellerhorst-Ryan JM; Turba EP; Stahl DL
Nurse Pract; 1988 Sep; 13(9):13, 16, 18, passim. PubMed ID: 3050626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
